NASDAQ: APTX       Aptinyx Inc
Last Price Today's Change   Day's Range   Trading Volume
3.15   0.00 (0.00%)  3.115 - 3.16  10,488


Avg Volume (4 weeks):72,615
4 Weeks Range:2.91 - 3.62
4 Weeks Price Volatility (%):
52 Weeks Range:2.61 - 26.74
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Aptinyx Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel, proprietary, synthetic small molecules for the treatment of brain and nervous system disorders. Its pipeline products are NYX-2925, NYX-458, and NYX-783. NYX-2925 is a novel, oral, small-molecule NMDA receptor modulator in clinical development as a therapy for chronic pain. NYX-2925 works by enhancing synaptic plasticity, a mechanism uniquely suited to addressing chronic pain, and NYX-783 is an NMDA receptor modulating small molecule in clinical development as a therapy for post-traumatic stress disorder.

  Be the first to like this.


1632  3880  560  2905 

Top 10 Active Counters
 CELG 108.24+0.11 
 ACB 3.03+0.39 
 AABA 19.630.00 
 AMD 39.717-1.263 
 UBER 29.20+1.17 
 CHK 0.575+0.005 
 M 14.59-0.43 
 SCHW 47.92+3.17 
 GGB 3.76+0.16 
 HEPA 3.67+1.25 
Partners & Brokers